Abstract
HuR, a ubiquitously expressed RNA-binding protein, stabilizes mRNA and regulates its translation. HuR expression was increased at all stages of breast cancer and correlated with poor clinical outcome. However, the detailed mechanisms remain unclear. Here we reported that overexpression of HuR increased CDK3 mRNA stability and thus its protein expression in MDA-MB-231 and MCF-7 cells. Mechanistically, CDK3 mRNA was identified as a target of HuR via bioinformatics and RNA binding protein immunoprecipitation (RIP) assays. Furthermore, treatment with HuR shRNA decreased CDK3 expression, inhibited cell proliferation and promoted cell apoptosis in breast cancer. More importantly, overexpression of CDK3 reversed the suppressive effects of HuR knockdown on cell growth in both MDA-MB-231 and MCF-7 cells. Finally, HuR and CDK3 expression levels were positively correlated and significantly up-regulated in breast cancer samples. And overexpression of HuR attenuated the chemotherapeutical efficiency of breast cancer. Therefore, our results indicate that ectopic expression of HuR promotes breast cancer cell proliferation and survival by directly binding to and stabilizing CDK3 mRNA.
Citations
Jan 19, 2018·Biotechnology Letters·Yu ZhangWei Heng
Jan 10, 2018·Cold Spring Harbor Perspectives in Biology·Adam M Heck, Jeffrey Wilusz
Sep 6, 2018·Cell Proliferation·Zhikun LiWei Xu
Sep 11, 2019·Cells·Yueshuang KeXueqing Ba
Jan 8, 2020·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Lei-Yun WangJi-Ye Yin
Jan 24, 2020·Wiley Interdisciplinary Reviews. RNA·Christopher W SchultzJonathan R Brody
Jun 10, 2020·Cell Proliferation·Jun XuLing Xu
Mar 8, 2018·International Journal of Oncology·Chen SuYi Zhang
Aug 14, 2020·Cellular and Molecular Life Sciences : CMLS·Yueshuang KeXueqing Ba
Mar 19, 2020·International Journal of Molecular Sciences·Lei DingQinghua Cui
Sep 17, 2020·International Journal of Molecular Sciences·Dobrochna DolickaMichelangelo Foti
Feb 28, 2018·Molecular Medicine Reports·Yunzhong ZhangXianai Zhu
May 18, 2020·Cancers·Clara RegleroPetronila Penela
Sep 30, 2020·Oral Diseases·Na LuPeng Zhang
Dec 30, 2020·Cell Proliferation·Zhenxuan ShaoXiangyang Wang
Apr 6, 2021·Frontiers in Oncology·Yongming LiuRan Zhuang
Jan 6, 2022·Bioengineered·Jun ShenJun Zhou